NauseaAntineoplastic Combined Chemotherapy ProtocolsInflammationInflammation MediatorsChemotherapy, AdjuvantCytokinesPostoperative Nausea and VomitingVomitingTumor Necrosis Factor-alphaInterleukin-8LipopolysaccharidesAntiemeticsMacrophagesNF-kappa BInterleukin-6Mice, Inbred C57BLCells, CulturedAntineoplastic AgentsToll-Like Receptor 4CisplatinToll-Like Receptor 2Combined Modality TherapyTreatment OutcomeSignal TransductionDoxorubicinCyclophosphamideInterleukin-1betaMonocytesMice, KnockoutSeoul virusMyeloid Differentiation Factor 88ChemokinesCell LineInterleukin-1OndansetronDrug Administration ScheduleRNA, MessengerGene Expression RegulationImmunity, InnateToll-Like ReceptorsNeoadjuvant TherapyDisease-Free SurvivalTime FactorsUp-RegulationBreast NeoplasmsInterleukin-10LungSurvival AnalysisEpithelial CellsDose-Response Relationship, DrugEtoposideMicrogliaNeoplasm StagingDisease Models, AnimalChemokine CCL2Survival RateReverse Transcriptase Polymerase Chain ReactionNeutrophilsLung NeoplasmsMacrophage ActivationEnzyme-Linked Immunosorbent AssayPrognosisNeoplasmsMethotrexateCarboplatinMice, Inbred BALB CAnti-Inflammatory AgentsInterferon-gammaPaclitaxelApoptosisNitric Oxide Synthase Type IIEndothelial CellsHMGB1 ProteinVinblastineToll-Like Receptor 9p38 Mitogen-Activated Protein KinasesGene ExpressionIntercellular Adhesion Molecule-1Toll-Like Receptor 6GranisetronMacrophages, PeritonealTaxoidsVomiting, AnticipatorySepsisAntigens, CD14I-kappa B ProteinsNeoplasm Recurrence, LocalDeoxycytidineBlotting, WesternInduction ChemotherapyCyclooxygenase 2Flow CytometryCell Line, TumorAntimetabolites, AntineoplasticTranscription Factor RelAIfosfamideDendritic CellsDrug Resistance, NeoplasmChemokine CCL5Prochlorperazine